Literature DB >> 8921951

Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein.

M A Haque1, S Yoshino, S Inada, H Nomaguchi, O Tokunaga, O Kohashi.   

Abstract

Oral administration of mycobacterial 65-kDa heat shock protein (HSP) given daily for 5 days prior to immunization with Mycobacterium tuberculosis (Mt) suppressed the development of adjuvant arthritis (AA) in rats. AA was significantly suppressed by 30 and 300 micrograms HSP, and variably by 0.3, 3 micrograms or 1 mg. Histological analysis of joint samples obtained from control and test rats confirmed the suppression of AA in the fed group. Feeding Mt or hen egg lysozyme (HEL) failed to affect AA, indicating that the suppression was HSP specific. The oral administration of 30 micrograms HSP decreased both delayed-type hypersensitivity (DTH) reactions and proliferative responses to HSP and Mt. In addition, the proliferation of lymph node cells (LNC) from Mt-sensitized rats was inhibited by the addition of spleen cells (SPC) from HSP-fed animals, possibly by the secretion of transforming growth factor (TGF)-beta. Spleen cells obtained from tolerized donors were capable of transferring the tolerance to naive recipients. These results demonstrate that feeding HSP is an effective way to suppress AA and that the suppression of AA may be mediated by regulatory T cells generated following oral administration of mycobacterial 65-kDa HSP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921951     DOI: 10.1002/eji.1830261116

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

Review 1.  Oral tolerance and the treatment of rheumatoid arthritis.

Authors:  H L Weiner; Y Komagata
Journal:  Springer Semin Immunopathol       Date:  1998

2.  Expression of Mycobacterium leprae HSP65 in tobacco and its effectiveness as an oral treatment in adjuvant-induced arthritis.

Authors:  César Rodríguez-Narciso; Mayra Pérez-Tapia; Rosa María Rangel-Cano; Celio L Silva; Mariana Meckes-Fisher; Rafael Salgado-Garciglia; Sergio Estrada-Parra; Rodolfo López-Gómez; Iris Estrada-García
Journal:  Transgenic Res       Date:  2010-06-06       Impact factor: 2.788

Review 3.  Vaccination strategies for mucosal immune responses.

Authors:  P L Ogra; H Faden; R C Welliver
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 4.  Treating arthritis by immunomodulation: is there a role for regulatory T cells?

Authors:  Ellen J Wehrens; Femke van Wijk; Sarah T Roord; Salvatore Albani; Berent J Prakken
Journal:  Rheumatology (Oxford)       Date:  2010-05-12       Impact factor: 7.580

Review 5.  Arthritis protective regulatory potential of self-heat shock protein cross-reactive T cells.

Authors:  W van Eden; U Wendling; L Paul; B Prakken; P van Kooten; R van der Zee
Journal:  Cell Stress Chaperones       Date:  2000-11       Impact factor: 3.667

Review 6.  Role of heat shock proteins in protection from and pathogenesis of infectious diseases.

Authors:  U Zügel; S H Kaufmann
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 7.  Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis.

Authors:  Shailesh R Satpute; Malarvizhi Durai; Kamal D Moudgil
Journal:  Semin Arthritis Rheum       Date:  2008-01-04       Impact factor: 5.532

8.  Autoreactive CD4- CD8- alpha beta T cells to vaccinate adjuvant arthritis.

Authors:  M A Haque; M Kimoto; S Inada; O Tokunaga; O Kohashi
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

9.  Tolerization with Hsp65 induces protection against adjuvant-induced arthritis by modulating the antigen-directed interferon-gamma, interleukin-17, and antibody responses.

Authors:  Shailesh R Satpute; Rajesh Rajaiah; Swamy K Polumuri; Kamal D Moudgil
Journal:  Arthritis Rheum       Date:  2009-01

10.  Self heat-shock protein 65-mediated regulation of autoimmune arthritis.

Authors:  Malarvizhi Durai; Min-Nung Huang; Kamal D Moudgil
Journal:  J Autoimmun       Date:  2009-10-02       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.